Illustration: Sarah Grillo/Axios

The use of telemedicine has exploded during the COVID-19 pandemic, and experts see the changes remaining even after the coronavirus.

Why it matters: Given its heavily regulated and fragmented nature, health care tends to be slow to adopt innovation. But the pandemic has shown Americans the advantages of communicating with doctors remotely — and health insurance companies are paying attention.

What's new: According to FAIR Health's Monthly Telehealth Regional Tracker, which draws from 31 billion private health care claim records, telemedicine claim lines increased an astounding 4,347% year-over-year in March.

Telemedicine services have been available for years, but health concerns around the pandemic combined with the fact that most doctor's offices and hospitals were effectively off-limits to non-COVID-19 patients have led millions of Americans to use their smartphone to access remote care for the first time.

  • The stock price of the leading telemedicine company Teladoc has risen by more than 30% since the beginning of March.

Telemedicine is only one aspect of the sclerotic health care sector that has been shaken up by the COVID-19 pandemic.

  • Wearable devices like the Apple Watch are being used in academic studies to predict when COVID-19 cases might occur.
  • Jeff Semenchuk, chief innovation officer at Blue Shield of California, says the pandemic has pushed his company to digitize health care whenever possible. That includes efforts to make electronic patient health records more easily accessible and to simplify the laborious process of payment claims.
"COVID-19 has accelerated what we're doing with innovation around health care. It's really hit the gas pedal."
— Jeff Semenchuk

Go deeper

CDC official: Pandemic "explosion" of antibiotic resistance not seen

Illustration: Sarah Grillo/Axios

Despite concerns over antimicrobial resistance flourishing during the pandemic as doctors use all their tools to help patients fight COVID-19, early indications are that their efforts may not be causing a large increase, a CDC official tells Axios.

Why it matters: AMR is a growing problem, as the misuse or overuse of antibiotics creates resistant pathogens that cause more than 2.8 million infections and 35,000 deaths annually in the U.S.

Judge orders Eric Trump to testify in New York probe before election

Photo: Ira L. Black/Corbis via Getty Images

A judge on Wednesday ordered Eric Trump to comply with a subpoena to testify before the presidential election in a New York probe into the Trump family business.

The state of play: New York Attorney General Letitia James (D) last month said her office had filed a lawsuit to compel the Trump Organization to comply with subpoenas related to an investigation into whether President Trump and his company improperly inflated the value of its assets on financial statements.

1 hour ago - Podcasts

Reid Hoffman and Mark Pincus on the rise of Silicon Valley SPACs

Silicon Valley venture capitalists are no longer content with investing in startups and then eventually handing them off. Instead, many are now forming SPACs, or blank-check acquisition companies, to ride tech unicorns into the public markets themselves.

Axios Re:Cap digs into this trend with the co-founders of a new tech SPAC called Reinvent Technology Partners: Reid Hoffman, a co-founder of LinkedIn and partner at Greylock, and Mark Pincus, the founder and former CEO of Zynga.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!